ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Adverse effects"

  • 2016 American Transplant Congress

    In Their Own Words: Living Kidney Donors Who Develop Kidney Failure.

    L. Ross,1 C. Halverson,2 J. Wang,1 M. Poulson,3 J. Karlin,4 M. Crowley-Matoka.5

    1U Chicago, Chicago, IL; 2Anthropology, U Chicago, Chicago, IL; 3Georgetown U, Washington, DC; 4Family Medicine, UCSF, San Francisco, CA; 5Medical Humanities, Northwestern U, Chicago, IL.

    Background: Psychosocial data about living kidney donation have been collected for almost five decades. The results are almost uniformly positive, even in the early years…
  • 2016 American Transplant Congress

    Everolimus versus Mycophenolate Mofetil in Combination with Tacrolimus: A Propensity Score Matching Analysis in Liver Transplantation.

    P. de Simone,1 P. Carrai,1 A. Precisi,2 L. Coletti,1 D. Ghinolfi,1 F. Filipponi.1

    1Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospitals, Pisa, Italy; 2Laboratory, University of Pisa Medical School Hospital, Pisa, Italy.

    Background: No trial has so far investigated everolimus (EVR)-incorporating immunosuppressive regimens versus combined use of tacrolimus (TAC) and mycophenolate mofetil (MMF) in liver transplantation (LT).Materials…
  • 2016 American Transplant Congress

    Pre-Transplant Intra-Arterial Liver Directed Therapy Does Not Increase the Risk of Hepatic Arterial Misadventures in Liver Transplantation.

    J. Kallini,2 A. Gabr,2 R. Salem,2 R. Lewandowski,2 T. Baker.1

    1Comprehensive Transplant Center, Northwestern University, Chicago, IL; 2Division of Interventional Oncology, Northwestern University, Chicago, IL.

    Background: Pretransplant liver directed therapy has emerged as standard of care for patients with end stage liver disease complicated by unresectable hepatocellular cancer. The aim…
  • 2016 American Transplant Congress

    Earlier Repletion of Lymphocytes After Alemtuzumab Induction Is Associated with a Lower Incidence of Infection Following Renal Transplantation.

    M. Willicombe, D. Goodall, A. McLean, D. Taube.

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    Introduction: Alemtuzumab has been increasingly used as an induction agent in renal transplantation, although the optimal dose is unknown. We have previously reported that alemtuzumab…
  • 2016 American Transplant Congress

    Chemoprevention of Cutaneous Squamous Cell Carcinoma in Renal Transplant Recipients: A Case-Controlled Analysis.

    R. Anand, R. Hung, S. Frame, K. Bramham, M. Wain, A. Cronin.

    Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.

    Organ transplant recipients are up to 200 times more likely to develop cutaneous squamous cell carcinoma (SCC) than age-matched general populations. Systemic retinoids, such as…
  • 2015 American Transplant Congress

    Quality of Life, Financial, and Mental Health Outcomes for Individuals Turned Down for Live Kidney Donation

    P. Reese,1 C. Carney,1 S. Levsky,1 R. Pendse,1 D. Leidy,1 A. Mussell,1 R. Bloom,1 M. Allen,1 D. Collins,1 S. Keddem,1 P. Abt,1 J. Rodrigue,2 E. Emanuel.1

    1UPenn, Philadelphia, PA; 2Harvard, Cambridge, MA.

    Introduction: Individuals considering live kidney donation should have a thorough understanding of the risks and benefits. Regulations focus exclusively on donation risks. However, no data…
  • 2015 American Transplant Congress

    Effect of Antibody Mediated Rejection on Long-Term Renal Allograft Function

    M. John, A. Smith, I. Dortonne, A. Paramesh, M. Killackey, B. Lee, R. Zhang, J. Buell.

    Transplant Institute, Tulane University, New Orleans, LA.

    Historically we had poor understanding of chronic rejection attributing it to hypertension and non-compliance. However in the last decade we have begun to understand the…
  • 2015 American Transplant Congress

    De Novo Once-Daily Tacrolimus in Liver Transplantation: Long-Term Outcomes of a Single Center Cohort of 150 Patients

    M. Gastaca, A. Valdivieso, J. Bustamante, P. Ruiz, J. Fernandez, A. Ventoso, M. Testillano, I. Palomares, P. Salvador, M. Prieto, A. Matarranz, M. Suarez, J. Ortiz de Urbina.

    Liver Transplantation Unit, Cruces University Hospital. University of the Basque Country, Bilbao, Vizcaya, Spain.

    Purpose: To describe the long-term safety and efficacy profile of de novo once-daily tacrolimus (Tac QD) in orthotopic liver transplantation (OLT)Patients and methods: A retrospective…
  • 2015 American Transplant Congress

    Tacrolimus Trough Concentrations Increase in Intestinal Transplant Recipients During Episodes of Acute Cellular Rejection

    A. Lichvar,1 D. Deen,2 H. Johnson,1 J. Bonner,3 G. Bond,4 G. Costa,4 R. Cruz,4 K. Abu-Elmagd,5 R. Venkataramanan.6,7

    1Department of Pharmacy and Therapeutics, University of Pittsburgh Medical Center, Pittsburgh, PA; 2Department of Pharmacy, Memorial University Medical Center, Savannah, GA; 3Northern Institute for Cancer Research at Newcastle University, Tyne and Wear, United Kingdom; 4Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA; 5Center for Gut Rehabilitation and Transplantation, Cleveland Clinic, Cleveland, OH; 6Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA; 7Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Introduction: Acute cellular rejection (ACR) in small bowel transplant recipients is expected to increase intestinal permeability and to reduce intestinal CYP3A/p-glycoprotein activity. These changes may…
  • 2015 American Transplant Congress

    Impact of Machine Perfusion After Long Static Cold Storage On Delayed Graft Function Incidence and Duration and Time to Hospital Discharge

    A. Matos,1 M. Borrelli, Jr.,1 L. Moura Requiao,1 M. Nogueira, Jr.,1 L. Pertusier,1 G. Clarizia,1 P. Ongaro,1 S. Ximenes,1 M. Durao, Jr.,1,2 A. Pacheco-Silva.1,2

    1Transplantation, Hospital Israelita Albert Einstein, Sao Paulo, Brazil; 2Medicine/Nephrology, Escola Paulista de Medicina, UNIFESP, Sao Paulo, Brazil.

    Our transplant center is not involved in organ harvesting and usually we receive a kidney for transplant with more then 20 hours of static cold…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences